References
1. Lucas A, Fewtrell MS, Cole TJ. Fetal origins of adult disease-the hypothesis revisited. BMJ. 1999;319(7204):245-249.
2. Ravn NH, Halling AS, Berkowitz AG, et al. How does parental history of atopic disease predict the risk of atopic dermatitis in a child? A systematic review and meta-analysis. J Allergy Clin Immunol.2020;145(4):1182-1193.
3. Lockett GA, Soto-Ramirez N, Ray MA, et al. Association of season of birth with DNA methylation and allergic disease. Allergy.2016;71(9):1314-1324.
4. Litonjua AA, Gold DR. Asthma and obesity: common early-life influences in the inception of disease. J Allergy Clin Immunol.2008;121(5):1075-1084; quiz 1085-1076.
5. Renz H, Holt PG, Inouye M, Logan AC, Prescott SL, Sly PD. An exposome perspective: Early-life events and immune development in a changing world. J Allergy Clin Immunol. 2017;140(1):24-40.
6. Jackson DJ, Gern JE, Lemanske RF, Jr. Lessons learned from birth cohort studies conducted in diverse environments. J Allergy Clin Immunol. 2017;139(2):379-386.
7. Skevaki C, Van den Berg J, Jones N, et al. Immune biomarkers in the spectrum of childhood noncommunicable diseases. J Allergy Clin Immunol. 2016;137(5):1302-1316.
8. Poissonnier A, Sanseau D, Le Gallo M, et al. CD95-Mediated Calcium Signaling Promotes T Helper 17 Trafficking to Inflamed Organs in Lupus-Prone Mice. Immunity. 2016;45(1):209-223.
9. Tauzin S, Chaigne-Delalande B, Selva E, et al. The naturally processed CD95L elicits a c-yes/calcium/PI3K-driven cell migration pathway. PLoS Biol. 2011;9(6):e1001090.
10. Daneshmandi S, Pourfathollah AA, Pourpak Z, Heidarnazhad H. Soluble Form of Fasl (sFasL) in Adult Asthma. Iran Red Crescent Med J.2009;11(3):301-305.
11. Mezei G, Levay M, Sepler Z, Heninger E, Kozma GT, Cserhati E. Seasonal changes of proapoptotic soluble Fas ligand level in allergic rhinitis combined with asthma. Pediatr Allergy Immunol.2006;17(6):444-449.
12. Su KW, Chen PC, Wang IJ. Cord blood soluble Fas ligand and pediatric atopic dermatitis. Allergy Asthma Proc. 2011;32(5):366-371.
13. Su KW, Tu YL, Chiu CY, et al. Cord Blood Soluble CD14 Predicts Wheeze and Prolonged Cough in Young Children: The PATCH Study. Int Arch Allergy Immunol. 2016;169(3):189-197.
14. Global Initiative for Asthma. Global Strategy for Asthma Management and Prevention. 2017; https://ginasthma.org/ .
15. Bousquet J, Khaltaev N, Cruz AA, et al. Allergic Rhinitis and its Impact on Asthma (ARIA) 2008 update (in collaboration with the World Health Organization, GA(2)LEN and AllerGen). Allergy. 2008;63 Suppl 86:8-160.
16. Hanifin JM. Atopic dermatitis. J Allergy Clin Immunol.1984;73(2):211-226.
17. Sunyer J, Anto JM, Castellsague J, Soriano JB, Roca J. Total serum IgE is associated with asthma independently of specific IgE levels. The Spanish Group of the European Study of Asthma. Eur Respir J.1996;9(9):1880-1884.
18. American Thoracic S, European Respiratory S. ATS/ERS recommendations for standardized procedures for the online and offline measurement of exhaled lower respiratory nitric oxide and nasal nitric oxide, 2005.Am J Respir Crit Care Med. 2005;171(8):912-930.
19. Miller MR, Hankinson J, Brusasco V, et al. Standardisation of spirometry. Eur Respir J. 2005;26(2):319-338.
20. İkincioğullari A, Doğu F, Bozdoğan G, et al. Serum sFas and sFas-Ligand Levels in Childhood Asthma. Pediatric Asthma, Allergy & Immunology. 2004;17(2):126-130.
21. Abe R. Toxic epidermal necrolysis and Stevens-Johnson syndrome: soluble Fas ligand involvement in the pathomechanisms of these diseases.J Dermatol Sci. 2008;52(3):151-159.
22. LA OR, Tai L, Lee L, et al. Membrane-bound Fas ligand only is essential for Fas-induced apoptosis. Nature.2009;461(7264):659-663.
23. Cullen SP, Henry CM, Kearney CJ, et al. Fas/CD95-induced chemokines can serve as ”find-me” signals for apoptotic cells. Mol Cell.2013;49(6):1034-1048.
24. Lau S, Illi S, Sommerfeld C, et al. Early exposure to house-dust mite and cat allergens and development of childhood asthma: a cohort study. Multicentre Allergy Study Group. Lancet.2000;356(9239):1392-1397.
25. Cox DW, Mullane D, Zhang GC, et al. Longitudinal assessment of airway responsiveness from 1 month to 18 years in the PIAF birth cohort.Eur Respir J. 2015;46(6):1654-1661.
Table 1. Cord blood soluble FasL level and allergic outcomes at 7 years old